- Home
- KVHI vs IGMS Comparison
KVHI vs IGMS Comparison
Compare KVHI & IGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KVHI
- IGMS
- Stock Information
- Founded
- KVHI 1978
- IGMS 1993
- Country
- KVHI United States
- IGMS United States
- Employees
- KVHI N/A
- IGMS N/A
- Industry
- KVHI Radio And Television Broadcasting And Communications Equipment
- IGMS Biotechnology: Pharmaceutical Preparations
- Sector
- KVHI Technology
- IGMS Health Care
- Exchange
- KVHI Nasdaq
- IGMS Nasdaq
- Market Cap
- KVHI 101.5M
- IGMS 82.1M
- IPO Year
- KVHI 1996
- IGMS 2019
- Fundamental
- Price
- KVHI $5.33
- IGMS $1.15
- Analyst Decision
- KVHI
- IGMS Hold
- Analyst Count
- KVHI 0
- IGMS 8
- Target Price
- KVHI N/A
- IGMS $6.00
- AVG Volume (30 Days)
- KVHI 17.4K
- IGMS 303.0K
- Earning Date
- KVHI 07-31-2025
- IGMS 08-13-2025
- Dividend Yield
- KVHI N/A
- IGMS N/A
- EPS Growth
- KVHI N/A
- IGMS N/A
- EPS
- KVHI N/A
- IGMS N/A
- Revenue
- KVHI $109,975,000.00
- IGMS $2,681,000.00
- Revenue This Year
- KVHI $1.02
- IGMS $134.30
- Revenue Next Year
- KVHI $12.63
- IGMS $22.37
- P/E Ratio
- KVHI N/A
- IGMS N/A
- Revenue Growth
- KVHI N/A
- IGMS 27.36
- 52 Week Low
- KVHI $4.17
- IGMS $0.92
- 52 Week High
- KVHI $6.16
- IGMS $22.50
- Technical
- Relative Strength Index (RSI)
- KVHI 52.53
- IGMS 49.42
- Support Level
- KVHI $5.16
- IGMS $1.12
- Resistance Level
- KVHI $5.50
- IGMS $1.40
- Average True Range (ATR)
- KVHI 0.21
- IGMS 0.07
- MACD
- KVHI -0.01
- IGMS -0.00
- Stochastic Oscillator
- KVHI 44.23
- IGMS 35.71
About KVHI KVH Industries Inc.
KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.